The power prior: theory and applications
Abstract
The power prior has been widely used in many applications covering a large number of disciplines. The power prior is intended to be an informative prior constructed from historical data. It has been used in clinical trials, genetics, health care, psychology, environmental health, engineering, economics, and business. It has also been applied for a wide variety of models and settings, both in the experimental design and analysis contexts. In this review article, we give an A‐to‐Z exposition of the power prior and its applications to date. We review its theoretical properties, variations in its formulation, statistical contexts for which it has been used, applications, and its advantages over other informative priors. We review models for which it has been used, including generalized linear models, survival models, and random effects models. Statistical areas where the power prior has been used include model selection, experimental design, hierarchical modeling, and conjugate priors. Frequentist properties of power priors in posterior inference are established, and a simulation study is conducted to further examine the empirical performance of the posterior estimates with power priors. Real data analyses are given illustrating the power prior as well as the use of the power prior in the Bayesian design of clinical trials. Copyright © 2015 John Wiley & Sons, Ltd.
Citing Literature
Number of times cited according to CrossRef: 51
- David J. Stewart, Dominick Bossé, Glenwood Goss, John F. Hilton, Derek Jonker, Michael Fung-Kee-Fung, A novel, more reliable approach to use of progression-free survival as a predictor of gain in overall survival, Critical Reviews in Oncology/Hematology, 10.1016/j.critrevonc.2020.102896, (102896), (2020).
- Haolun Shi, Teng Zhang, Guosheng Yin, START: single‐to‐double arm transition design for phase II clinical trials, Pharmaceutical Statistics, 10.1002/pst.2005, 19, 4, (454-467), (2020).
- Suresh Ankolekar, Cyrus Mehta, Rajat Mukherjee, Sam Hsiao, Jennifer Smith, Tarek Haddad, Monte Carlo Simulation for Trial Design Tool, Principles and Practice of Clinical Trials, 10.1007/978-3-319-52677-5, (1-23), (2020).
- Manuel Feißt, Johannes Krisam, Meinhard Kieser, Incorporating historical two‐arm data in clinical trials with binary outcome: A practical approach, Pharmaceutical Statistics, 10.1002/pst.2023, 19, 5, (662-678), (2020).
- Yimei Li, Ying Yuan, PA‐CRM: A continuous reassessment method for pediatric phase I oncology trials with concurrent adult trials, Biometrics, 10.1111/biom.13217, 0, 0, (2020).
- Jingjing Ye, Gregory Reaman, R. Angelo De Claro, Rajeshwari Sridhara, A Bayesian approach in design and analysis of pediatric cancer clinical trials, Pharmaceutical Statistics, 10.1002/pst.2039, 0, 0, (2020).
- Andrea Arfè, Brian Alexander, Lorenzo Trippa, Optimality of testing procedures for survival data in the nonproportional hazards setting, Biometrics, 10.1111/biom.13315, 0, 0, (2020).
- Heng Li, Wei-Chen Chen, Nelson Lu, Chenguang Wang, Ram Tiwari, Yunling Xu, Lilly Q. Yue, Novel statistical approaches and applications in leveraging real-world data in regulatory clinical studies, Health Services and Outcomes Research Methodology, 10.1007/s10742-020-00218-4, (2020).
- Annette Kopp‐Schneider, Silvia Calderazzo, Manuel Wiesenfarth, Power gains by using external information in clinical trials are typically not possible when requiring strict type I error control, Biometrical Journal, 10.1002/bimj.201800395, 62, 2, (361-374), (2019).
- Mario Nagase, Shinya Ueda, Mitsuo Higashimori, Katsuomi Ichikawa, James Dunyak, Nidal Al‐Huniti, Optimal designs for regional bridging studies using the Bayesian power prior method, Pharmaceutical Statistics, 10.1002/pst.1967, 19, 1, (22-30), (2019).
- Manuel Wiesenfarth, Silvia Calderazzo, Quantification of prior impact in terms of effective current sample size, Biometrics, 10.1111/biom.13124, 76, 1, (326-336), (2019).
- Han Du, Thomas N. Bradbury, Justin A. Lavner, Andrea L. Meltzer, James K. McNulty, Lisa A. Neff, Benjamin R. Karney, A comparison of Bayesian synthesis approaches for studies comparing two means: A tutorial, Research Synthesis Methods, 10.1002/jrsm.1365, 11, 1, (36-65), (2019).
- Emily A. Hennessy, Blair T. Johnson, Examining overlap of included studies in meta‐reviews: Guidance for using the corrected covered area index, Research Synthesis Methods, 10.1002/jrsm.1390, 11, 1, (134-145), (2019).
- Dimitris Mavridis, Ian R. White, Dealing with missing outcome data in meta‐analysis, Research Synthesis Methods, 10.1002/jrsm.1349, 11, 1, (2-13), (2019).
- Howard Thom, José A. López‐López, Nicky J. Welton, Shared parameter model for competing risks and different data summaries in meta‐analysis: Implications for common and rare outcomes, Research Synthesis Methods, 10.1002/jrsm.1371, 11, 1, (91-104), (2019).
- Wing Tung Fung, Joseph T. Wu, Wai Man Mandy Chan, Henry H. Chan, Herbert Pang, Pathway‐based meta‐analysis for partially paired transcriptomics analysis, Research Synthesis Methods, 10.1002/jrsm.1381, 11, 1, (123-133), (2019).
- Burak Kürsad Günhan, Christian Röver, Tim Friede, Random‐effects meta‐analysis of few studies involving rare events, Research Synthesis Methods, 10.1002/jrsm.1370, 11, 1, (74-90), (2019).
- Orestis Efthimiou, Ian R. White, The dark side of the force: Multiplicity issues in network meta‐analysis and how to address them, Research Synthesis Methods, 10.1002/jrsm.1377, 11, 1, (105-122), (2019).
- Fabiola La Gamba, Tom Jacobs, Helena Geys, Thomas Jaki, Jan Serroyen, Moreno Ursino, Alberto Russu, Christel Faes, Bayesian sequential integration within a preclinical pharmacokinetic and pharmacodynamic modeling framework: Lessons learned, Pharmaceutical Statistics, 10.1002/pst.1941, 18, 4, (486-506), (2019).
- Linas Mockus, Gintaras Reklaitis, Kenneth Morris, David LeBlond, Risk-based Approach to Lot Release, Journal of Pharmaceutical Sciences, 10.1016/j.xphs.2019.10.011, (2019).
- Ying Yang, Yunling Xu, Nelson T. Lu, Ram C. Tiwari, A Bayesian Constancy-Enforced Non-Inferiority Design in Medical Device Trials with a Binary Endpoint, Contemporary Biostatistics with Biopharmaceutical Applications, 10.1007/978-3-030-15310-6_13, (239-249), (2019).
- Mohamed Amine Bayar, Anastasia Ivanova, Gwénaël Le Teuff, CRM2DIM: A SAS macro for implementing the Dual-Agent Bayesian Continual Reassessment Method, Computer Methods and Programs in Biomedicine, 10.1016/j.cmpb.2019.04.025, (2019).
- Björn Holzhauer, Methods for Using Aggregate Historical Control Data in Meta-Analyses of Clinical Trials With Time-to-Event Endpoints, Statistics in Biopharmaceutical Research, 10.1080/19466315.2019.1610043, (1-15), (2019).
- Ji Yeh Choi, Minjung Kyung, Heungsun Hwang, Ju-Hyun Park, Bayesian Extended Redundancy Analysis: A Bayesian Approach to Component-based Regression with Dimension Reduction, Multivariate Behavioral Research, 10.1080/00273171.2019.1598837, (1-19), (2019).
- Adrien Ollier, Satoshi Morita, Moreno Ursino, Sarah Zohar, An adaptive power prior for sequential clinical trials – Application to bridging studies, Statistical Methods in Medical Research, 10.1177/0962280219886609, (096228021988660), (2019).
- Isaac Gravestock, Leonhard Held, Power priors based on multiple historical studies for binary outcomes, Biometrical Journal, 10.1002/bimj.201700246, 61, 5, (1201-1218), (2018).
- Gaelle Saint‐Hilary, Valentine Barboux, Matthieu Pannaux, Mauro Gasparini, Veronique Robert, Gianluca Mastrantonio, Predictive probability of success using surrogate endpoints, Statistics in Medicine, 10.1002/sim.8060, 38, 10, (1753-1774), (2018).
- Jing Zhang, Chia-Wen Ko, Lei Nie, Yong Chen, Ram Tiwari, Bayesian hierarchical methods for meta-analysis combining randomized-controlled and single-arm studies, Statistical Methods in Medical Research, 10.1177/0962280218754928, 28, 5, (1293-1310), (2018).
- TB Brakenhoff, KCB Roes, S Nikolakopoulos, Bayesian sample size re-estimation using power priors, Statistical Methods in Medical Research, 10.1177/0962280218772315, 28, 6, (1664-1675), (2018).
- Matthew A. Psioda, Joseph G. Ibrahim, Bayesian design of a survival trial with a cured fraction using historical data, Statistics in Medicine, 10.1002/sim.7846, 37, 26, (3814-3831), (2018).
- Matthew A. Psioda, Mat Soukup, Joseph G. Ibrahim, A practical Bayesian adaptive design incorporating data from historical controls, Statistics in Medicine, 10.1002/sim.7897, 37, 27, (4054-4070), (2018).
- Barry Schouten, Nino Mushkudiani, Natalie Shlomo, Gabi Durrant, Peter Lundquist, James Wagner, A Bayesian Analysis of Design Parameters in Survey Data Collection, Journal of Survey Statistics and Methodology, 10.1093/jssam/smy012, 6, 4, (431-464), (2018).
- Kuk Jang, James Weimer, Houssam Abbas, Zhihao Jiang, Jackson Liang, Sanjay Dixit, Rahul Mangharam, undefined, 2018 40th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC), 10.1109/EMBC.2018.8513284, (1-4), (2018).
- Philip S Boonstra, Ryan P Barbaro, Incorporating historical models with adaptive Bayesian updates, Biostatistics, 10.1093/biostatistics/kxy053, (2018).
- Olav B Vassend, A Verisimilitude Framework for Inductive Inference, with an Application to Phylogenetics, The British Journal for the Philosophy of Science, 10.1093/bjps/axy054, (2018).
- David Dejardin, Paul Delmar, Charles Warne, Katie Patel, Joost van Rosmalen, Emmanuel Lesaffre, Use of a historical control group in a noninferiority trial assessing a new antibacterial treatment: A case study and discussion of practical implementation aspects, Pharmaceutical Statistics, 10.1002/pst.1843, 17, 2, (169-181), (2017).
- Stavros Nikolakopoulos, Ingeborg Tweel, Kit C. B. Roes, Dynamic borrowing through empirical power priors that control type I error, Biometrics, 10.1111/biom.12835, 74, 3, (874-880), (2017).
- Wenqing Li, Ming-Hui Chen, Xiaojing Wang, Dipak K. Dey, Bayesian Design of Non-inferiority Clinical Trials Via the Bayes Factor, Statistics in Biosciences, 10.1007/s12561-017-9200-5, 10, 2, (439-459), (2017).
- Stanley E Lazic, Nicholas Edmunds, Christopher E Pollard, Predicting Drug Safety and Communicating Risk: Benefits of a Bayesian Approach, Toxicological Sciences, 10.1093/toxsci/kfx236, 162, 1, (89-98), (2017).
- Christoph König, Rens van de Schoot, Bayesian statistics in educational research: a look at the current state of affairs, Educational Review, 10.1080/00131911.2017.1350636, 70, 4, (486-509), (2017).
- Isaac Gravestock, Leonhard Held, Adaptive power priors with empirical Bayes for clinical trials, Pharmaceutical Statistics, 10.1002/pst.1814, 16, 5, (349-360), (2017).
- Orestis Efthimiou, Dimitris Mavridis, Thomas P. A. Debray, Myrto Samara, Mark Belger, George C. M. Siontis, Stefan Leucht, Georgia Salanti, Combining randomized and non‐randomized evidence in network meta‐analysis, Statistics in Medicine, 10.1002/sim.7223, 36, 8, (1210-1226), (2017).
- Ivan Lorencin, MiloS Pantos, Evaluating Generating Unit Unavailability Using Bayesian Power Priors, IEEE Transactions on Power Systems, 10.1109/TPWRS.2016.2603469, 32, 3, (2315-2323), (2017).
- Katharina Hees, Meinhard Kieser, Blinded sample size recalculation in clinical trials incorporating historical data, Contemporary Clinical Trials, 10.1016/j.cct.2017.07.013, 63, (2-7), (2017).
- Tarek Haddad, Adam Himes, Laura Thompson, Telba Irony, Rajesh Nair, Incorporation of stochastic engineering models as prior information in Bayesian medical device trials, Journal of Biopharmaceutical Statistics, 10.1080/10543406.2017.1300907, 27, 6, (1089-1103), (2017).
- Joost van Rosmalen, David Dejardin, Yvette van Norden, Bob Löwenberg, Emmanuel Lesaffre, Including historical data in the analysis of clinical trials: Is it worth the effort?, Statistical Methods in Medical Research, 10.1177/0962280217694506, (096228021769450), (2017).
- Junsheng Ma, Brian P Hobbs, Francesco C Stingo, Integrating genomic signatures for treatment selection with Bayesian predictive failure time models, Statistical Methods in Medical Research, 10.1177/0962280216675373, 27, 7, (2093-2113), (2016).
- Ben Li, Yunxiao Li, Zhaohui S. Qin, Improving Hierarchical Models Using Historical Data with Applications in High-Throughput Genomics Data Analysis, Statistics in Biosciences, 10.1007/s12561-016-9156-x, 9, 1, (73-90), (2016).
- Graeme T. Spence, David Steinsaltz, Thomas R. Fanshawe, A Bayesian approach to sequential meta‐analysis, Statistics in Medicine, 10.1002/sim.7052, 35, 29, (5356-5375), (2016).
- Md S. Warasi, Joshua M. Tebbs, Christopher S. McMahan, Christopher R. Bilder, Estimating the prevalence of multiple diseases from two‐stage hierarchical pooling, Statistics in Medicine, 10.1002/sim.6964, 35, 21, (3851-3864), (2016).
- Pablo Emilio Verde, A bias‐corrected meta‐analysis model for combining, studies of different types and quality, Biometrical Journal, 10.1002/bimj.201900376, 0, 0, (undefined).




